Andrew Bascand: Investing in new technology episode artwork

EPISODE · Sep 17, 2023 · 40 MIN

Andrew Bascand: Investing in new technology

from The Weekend Collective · host Newstalk ZB

Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and macro investors. Listen in for your chance to get ahead of the markets. LISTEN ABOVESee omnystudio.com/listener for privacy information.

NOW PLAYING

Andrew Bascand: Investing in new technology

0:00 40:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Weekend Collective?

This episode is 40 minutes long.

When was this The Weekend Collective episode published?

This episode was published on September 17, 2023.

What is this episode about?

Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and...

Can I download this The Weekend Collective episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!